A Phase I dose escalation study of intrapleural administration of Oncofid-P-M in patients with unresectable recurrent/progressive pleural mesothelioma after first-line treatment

What you commit to

• Study type: Interventional · Phase 1
• Planned participants: 30
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with pleural mesothelioma that cannot be removed by surgery and has come back or is getting worse after first-line treatment.

Age

18 years or older

Sex

Women and men can join.

Disease stage

Pleural mesothelioma that cannot be removed by surgery and has come back or is progressing.

Earlier treatment

Must have had first-line treatment already.

Read by machine on 9 Nov 2026.

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details